Purpose

The goals of the NIH Nanomedicine Roadmap Initiative are to 1) obtain a comprehensive set of measurements on molecules and assemblies of molecules, and use those measurements to understand molecular pathways and networks, and 2) use that knowledge to drive the design and development of new nanomachines and technologies to improve human health.

To launch this initiative, NIH will support Nanomedicine Development Centers. This public meeting was held to discuss the NIH vision for these Centers, receive comments from the scientific community, and announce the details of a new funding opportunity (RFA) for planning these Centers.

Agenda

Note: Slide presentations from the webcast can be viewed by clicking on the PDF icon under the session or speaker name.
8:00 a.m.	Welcome Raynard Kington, Deputy Director, NIH Slide Presentation Paul Sieving, Director, NEI Slide Presentation
8:15 a.m.	The NIH Roadmap and Nanomedicine Development Centers Jeff Schloss, National Human Genome Research Institute Slide Presentation
9:00 a.m.	Session I: A Multidisciplinary Approach to Nanomedicine An example of multiple scientific perspectives needed to elucidate and apply design principles for reverse engineering
	Moderator: Catherine Lewis, National Institute of General Medical Sciences Slide Presentation
	Speakers:
	Steve Goldstein, Yale University Ion Channels: Nano-Mediators of Health, Disease and Therapy Slide Presentation
	Peter Agre, Johns Hopkins University Aquaporin Water Channels: Structures and Functions Slide Presentation
	Hagan Bayley, University of Oxford, UK Emerging Strategies for Engineering Channels and Pores Slide Presentation
	Eric Jakobsson, NIH and University of Illinois Multiscale Simulations of Ion Channel Function Using Tools and Principles from Computational Chemistry and Device Design Slide Presentation
10:45 a.m.	Session II:  Targets for Nanomedicine Research A moderated discussion of additional examples of scientific target areas for Nanomedicine research
	Moderator: Eleni Kousvelari, National Institute of Dental and Craniofacial Research
	Discussion Leaders: Carlo Montemagno, UCLA James Baker, University of Michigan
1:15 p.m.	Session III:  Creating Nanomedicine Research Teams A moderated discussion of strategies to establish Nanomedicine research teams
	Moderators: Dan Gallahan, NCI; Kuan Wang, NIAMS Slide Presentation
	Panel members:
	Denice Denton, University of Washington Dean, College of Engineering Slide Presentation
	Ueli Aebi, Biozentrum,University of Basel National Center of Competence in Research: Nanoscale Science
	Chih-Ming Ho, UCLA Institute for Cell Mimetic Space Exploration Slide Presentation
	Stuart Schreiber, Harvard University Institute of Chemistry and Cell Biology Slide Presentation
	David Thomassen, US Department of Energy DOE Genomes to Life Program
2:30 p.m.	Session IV:  Innovative Strategies for NIH Funding of Nanomedicine Application Process and Timeline; New NIH funding authorities for Nanomedicine
	Speaker: Richard S. Fisher, NEI Slide Presentation

Up to Top